Princeton Capital Management’s Accretive Health AH Stock Holding History

Princeton Capital Management’s Portfolio AH Stock Details AH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$93K	Hold	41,123	–	–	0.13%	79
2016 Q3	$100K	Hold	41,123	–	–	0.12%	75
2016 Q2	$82K	Hold	41,123	–	–	0.09%	73
2016 Q1	$105K	Hold	41,123	–	–	0.12%	72
2015 Q4	$132K	Hold	41,123	–	–	0.15%	72
2015 Q3	$102K	Hold	41,123	–	–	0.12%	80
2015 Q2	$226K	Hold	41,123	–	–	0.23%	79
2015 Q1	$238K	Buy	+41,123	New	+$238K	0.23%	77

Other funds holding AH

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RMC

Regis Management Company Menlo Park, California $331M AUM 14.13% 1-Year Est. Return

Princeton Capital Management's AH Position: Q4 2016 in Review

Princeton Capital Management held its Accretive Health (AH) position steady in Q4 2016 at 41,123 shares worth $93K. The position accounts for 0.13% of the portfolio, ranked #79.

Princeton Capital Management first reported a position in AH in Q1 2015 and has held it in 8 quarters since. The position peaked at $238K in Q1 2015. 5 funds tracked by Wall St. Rank hold AH as of Q4 2016.

Princeton Capital Management held 41,123 shares of Accretive Health worth $93K as of Q4 2016.
Princeton Capital Management left its Accretive Health share count unchanged in Q4 2016.
Accretive Health made up 0.13% of Princeton Capital Management's portfolio in Q4 2016, its #79 holding.
Princeton Capital Management first reported a position in Accretive Health in Q1 2015 and has held it in 8 quarters since.
Princeton Capital Management's Accretive Health position peaked at $238K in Q1 2015.
5 funds tracked by Wall St. Rank held Accretive Health as of Q4 2016.

Based on Princeton Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.